Review Articles
1. Bladder cancer, a two phased disease?
- Author
- Hoglund M;
- Institution
- Department of Clinical Genetics, Lund University Hospital, Lund SE-221 81, Sweden. mattias.hoglund@med.lu.se
- Journal
- Semin Cancer Biol. 2007 Jun;17(3):225-32. Epub 2006 Feb 28.
- Abstract URL
- Click here to view abstract
2. Novel therapeutic targets in bladder cancer: mutation and expression of FGF receptors.
- Author
- Knowles MA;
- Institution
- Cancer Research UK Clinical Centre, Section of Oncology, Leeds Institute of Molecular Medicine, St James's University Hospital, Beckett Street, Leeds, LS9 7TF, UK. m.a.knowles@leeds.ac.uk
- Journal
- Future Oncol. 2008 Feb;4(1):71-83.
- Abstract URL
- Click here to view abstract
3. Biological markers in the diagnosis of recurrent bladder cancer: an overview.
- Author
- Mohammed A; Khan Z; Zamora I; Bhatti A;
- Institution
- Urology Unit, North Tees University Hospital Hardwick Road, Stockton on Tees TS19 8PE, UK. aza_bamerny@yahoo.com
- Journal
- Expert Rev Mol Diagn. 2008 Jan;8(1):63-72.
- Abstract URL
- Click here to view abstract
4. Current status of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer.
- Author
- Rosenberg JE;
- Institution
- UCSF Comprehensive Cancer Center, 1600 Divisadero Street, Box 1711, San Francisco, CA 94115, USA. jrosenbe@medicine.ucsf.edu
- Journal
- Expert Rev Anticancer Ther. 2007 Dec;7(12):1729-36.
- Abstract URL
- Click here to view abstract
5. The best treatment for high-grade T1 bladder cancer is cystectomy.
- Author
- Skinner EC;
- Institution
- Department of Urology, Keck University of Southern California School of Medicine, Los Angeles, CA 90089, USA. skinner@hsc.usc.edu
- Journal
- Urol Oncol. 2007 Nov-Dec;25(6):523-5.
- Abstract URL
- Click here to view abstract
6. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update.
- Author
- Hall MC; Chang SS; Dalbagni G; Pruthi RS; Seigne JD; Skinner EC; Wolf JS Jr; Schellhammer PF;
- Institution
- American Urological Association Education and Research, Inc., USA. Craig.Hall@cornerstonehealthcare.com
- Journal
- J Urol. 2007 Dec;178(6):2314-30.
7. Pathological variants of invasive bladder cancer according to their suggested clinical significance.
- Author
- Lopez-Beltran A; Requena MJ; Cheng L; Montironi R;
- Institution
- Department of Pathology, Reina Sofia University Hospital and Cordoba University Medical School, Cordoba, Spain. em1lobea@uco.es
- Journal
- BJU Int. 2008 Feb;101(3):275-81. Epub 2007 Nov 6.
- Abstract URL
- Click here to view abstract
8. Surgery insight: advantages and disadvantages of laparoscopic radical cystectomy to treat invasive bladder cancer.
- Author
- Puppo P; Introini C; Naselli A;
- Institution
- Largo Rosanna Benzi 10, National Institute for Cancer Research, Genoa, Italy. paolo.puppo@auro.it
- Journal
- Nat Clin Pract Urol. 2007 Jul;4(7):387-94.
- Abstract URL
- Click here to view abstract
9. Muscle-invasive urothelial carcinoma of the bladder.
- Author
- Malkowicz SB; van Poppel H; Mickisch G; Pansadoro V; Thuroff J; Soloway MS; Chang S; Benson M; Fukui I;
- Institution
- Department of Urology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
- Journal
- Urology. 2007 Jan;69(1 Suppl):3-16.
- Abstract URL
- Click here to view abstract
10. An updated review of the literature: risk factors for bladder cancer with focus on occupational exposures.
- Author
- Olfert SM; Felknor SA; Delclos GL;
- Institution
- University of Texas School of Public Health at Houston, Southwest Center for Occupational and Environmental Health, Houston, TX 77030, USA.
- Journal
- South Med J. 2006 Nov;99(11):1256-63.
- Abstract URL
- Click here to view abstract
Previous Section
